Nayden Denis 4
4 · Accretive Health, Inc. · Filed Jul 5, 2012
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2012-07-02$5.52/sh+2,717$14,998→ 2,717 totalExercise: $11.43From: 2012-07-02Exp: 2022-07-02→ Common Stock (2,717 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.